MoneyWorks4Me

A fair growth of 9.20% in the revenue at Rs. 10399.00 millions was reported in the June 2025 quarter as compared to Rs. 9523.10 millions during year-ago period.A humble growth in net profit of 14.22% reported in the quarter ended June 2025 to Rs. 1978.70  millions from Rs. 1732.30 millions.The company reported a good operating profit of 3070.20 millions compared to 2785.40 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 10399.00 9523.10 9.20 10399.00 9523.10 9.20 37229.20 32986.40 12.86
Other Income 139.00 51.60 169.38 139.00 51.60 169.38 347.40 346.80 0.17
PBIDT 3070.20 2785.40 10.22 3070.20 2785.40 10.22 10526.80 9141.00 15.16
Interest 6.60 43.20 -84.72 6.60 43.20 -84.72 91.20 405.20 -77.49
PBDT 3063.60 2742.20 11.72 3063.60 2742.20 11.72 10435.60 8735.80 19.46
Depreciation 414.00 400.10 3.47 414.00 400.10 3.47 1664.50 1352.40 23.08
PBT 2649.60 2342.10 13.13 2649.60 2342.10 13.13 8771.10 7383.40 18.79
TAX 670.90 609.80 10.02 670.90 609.80 10.02 2245.70 1949.80 15.18
Deferred Tax 39.00 83.70 -53.41 39.00 83.70 -53.41 328.80 494.90 -33.56
PAT 1978.70 1732.30 14.22 1978.70 1732.30 14.22 6525.40 5433.60 20.09
Equity 156.10 155.20 0.58 156.10 155.20 0.58 155.70 155.20 0.32
PBIDTM(%) 29.52 29.25 0.94 29.52 29.25 0.94 28.28 27.71 2.04
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..